Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Rotmensz

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term tolerability of fenretinide (4-HPR) in breast cancer patientsN Rotmensz, G De Palo, F Formelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2006
Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgeryA Cardillo, C De Cicco, G Paganelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situG Curigliano, D Disalvatore, A Esposito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2009
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancerM Colleoni, V Bagnardi, N Rotmensz, et al.
British Journal of Cancer|May 29, 2008
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancerE Montagna, V Bagnardi, N Rotmensz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervixJ. B. Vermorken, C. Mangioni, S. Pecorelli, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 15, 2013
Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstructionM C Kneubil, J Brollo, E Botteri, et al.
British Journal of Cancer|July 2, 1998
Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative GroupM Bontenbal, M Andersson, J Wildiers, et al.
Annals of Surgical Oncology|December 18, 2014
Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of OncologyM Intra, G Viale, J Vila, et al.
Breast Cancer Research and Treatment|November 13, 2008
Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality?F Didier, D Radice, S Gandini, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term tolerability of fenretinide (4-HPR) in breast cancer patientsN Rotmensz, G De Palo, F Formelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2006
Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgeryA Cardillo, C De Cicco, G Paganelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situG Curigliano, D Disalvatore, A Esposito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2009
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancerM Colleoni, V Bagnardi, N Rotmensz, et al.
British Journal of Cancer|May 29, 2008
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancerE Montagna, V Bagnardi, N Rotmensz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervixJ. B. Vermorken, C. Mangioni, S. Pecorelli, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 15, 2013
Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstructionM C Kneubil, J Brollo, E Botteri, et al.
British Journal of Cancer|July 2, 1998
Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative GroupM Bontenbal, M Andersson, J Wildiers, et al.
Annals of Surgical Oncology|December 18, 2014
Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of OncologyM Intra, G Viale, J Vila, et al.
Breast Cancer Research and Treatment|November 13, 2008
Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality?F Didier, D Radice, S Gandini, et al.
Pageof 10